Clinical Consideration for the Treatment of GSM

Dr Nick Panay, MSc, MBBS, FRCOG, MFSHR

Honorary Senior Lecturer, Imperial College Director, West London Menopause and PMS Center Queen Charlotte’s and Chelsea Westminster Hospitals General Secretary-Elect of the International Menopause Society

Dr Panay reviews why discussion of treatment options for genitourinary syndrome of menopause (GSM) is often overlooked in patient visits. He explains the differences in performance and frequency of use of both moisturizers and lubricants and how the FDA-approved nonestrogen prasterone works.

Content updated 22 January 2018